2025 Partners
Alloy Therapeutics
Expertise Partner
Alloy’s Keyway TCR Discovery is a proprietary, integrated, end-to-end service for generating highly-specific
therapeutically-optimized TCR mimic leads. From immunizing our industry-leading ATX-Gx mice with high-quality protein-HLA complexes, to pairing in vitro and AI/ML capabilities for broad developability and specificity screening, to state-of-art engineering and bespoke functional screening capabilities. Integrating our discovery capabilities with our expertise in multi specifics engineering, Alloy is well placed to meet the needs of the rapidly developing therapeutic T-Cell Engager field